Applied Therapeutics, Inc. (APLT)

NASDAQ: APLT · IEX Real-Time Price · USD

4.460

+0.050 (1.13%)

At close: Apr 23, 2024, 4:00 PM

4.590

+0.130 (2.91%)

After-hours: Apr 23, 2024, 6:03 PM EDT

Applied Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	9.99	0	0	0	0	0	0
Gross Profit	9.99	0	0	0	0	0	0
Selling, General & Admin	20.62	27.32	43.05	32.68	13.23	2.05	0.58
Research & Development	53.91	55.63	62.57	61.79	32.35	11.47	3.7
Operating Expenses	74.53	82.95	105.62	94.47	45.58	13.52	4.29
Operating Income	-64.54	-82.95	-105.62	-94.47	-45.58	-13.52	-4.29
Interest Expense / Income	0	0	0	0.56	0.09	1.64	-0
Other Expense / Income	55.23	-0.44	-0.03	-1.06	-0.16	1.36	-
Pretax Income	-119.76	-82.51	-105.58	-93.96	-45.51	-16.52	-4.28
Net Income	-119.76	-82.51	-105.58	-93.96	-45.51	-16.52	-4.28
Shares Outstanding (Basic)	84	38	26	22	13	5	5
Shares Outstanding (Diluted)	84	38	26	22	13	5	5
Shares Change	122.72%	47.77%	16.53%	71.19%	134.01%	1.42%	-
EPS (Basic)	-1.42	-2.18	-4.12	-4.28	-3.55	-3.01	-0.79
EPS (Diluted)	-1.42	-2.18	-4.12	-4.28	-3.55	-3.01	-0.79
Free Cash Flow	-55.17	-78.09	-90.73	-78.21	-36.31	-11.18	-3.2
Free Cash Flow Per Share	-0.66	-2.06	-3.54	-3.56	-2.83	-2.04	-0.59
Gross Margin	100.00%	-	-	-	-	-	-
Operating Margin	-645.80%	-	-	-	-	-	-
Profit Margin	-1198.47%	-	-	-	-	-	-
Free Cash Flow Margin	-552.12%	-	-	-	-	-	-
EBITDA	-119.41	-82.07	-105.17	-93.02	-45.4	-14.88	-4.29
EBITDA Margin	-1194.94%	-	-	-	-	-	-
Depreciation & Amortization	0.35	0.44	0.42	0.38	0.02	0	0
EBIT	-119.76	-82.51	-105.58	-93.4	-45.42	-14.88	-4.29
EBIT Margin	-1198.47%	-	-	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).